By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Cleveland Biolabs Inc. 

10265 Carnegie Avenue

Cleveland  Ohio  44106  U.S.A.
Phone: 216-445-0814 Fax: 216-636-3429


SEARCH JOBS



Segment
Start Up





Company News
Cleveland Biolabs Inc. (CBLI) Enters Into Private Placement Agreement With Strategic Investor For $25 Million Equity Financing 6/25/2015 12:46:09 PM
Cleveland Biolabs Inc. (CBLI) Submits Pre-EUA Dossier For Entolimod To FDA 6/16/2015 12:49:48 PM
ASCO15: Cleveland Biolabs Inc. (CBLI) Releases Entolimod Phase 1 Study Findings At ASCO 6/2/2015 11:08:55 AM
Cleveland Biolabs Inc. (CBLI) Reports First Quarter 2015 Financial Results And Development Progress 5/6/2015 6:19:12 AM
Cleveland Biolabs Inc. (CBLI) Announces Appointment Of Biotechnology Industry Veteran, Langdon Miller, MD, As President And Chief Medical Officer 5/5/2015 11:30:02 AM
Cleveland Biolabs Inc. (CBLI) To Report First Quarter 2015 Financial Results On May 6 4/30/2015 9:39:15 AM
Cleveland Biolabs Inc. (CBLI) Enters Into Agreement To Raise Up To $4 Million Through Sales Of Equity Stake In Incuron Joint Venture 4/29/2015 10:13:35 AM
Cleveland Biolabs Inc. (CBLI) And Roswell Park Cancer Institute Announce Award Of Department Of Defense Breast Cancer Research Program Breakthrough Grant For Entolimod 4/27/2015 11:26:59 AM
Cleveland Biolabs Inc. (CBLI) Announces Acceptance Of Entolimod Phase 1 Study Findings For Poster Presentation At ASCO 4/24/2015 1:55:58 PM
Cleveland Biolabs Inc. (CBLI) Receives Funding Recommendation From Department Of Defense For Additional Development Proposal For Entolimod (CBLB502) As A Medical Radiation Countermeasure 4/16/2015 2:03:14 PM
12345678910...
//-->